Cargando…
Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923159/ https://www.ncbi.nlm.nih.gov/pubmed/31801934 http://dx.doi.org/10.2176/nmc.st.2019-0177 |
_version_ | 1783481472154337280 |
---|---|
author | TOYODA, Kazunori KOGA, Masatoshi IGUCHI, Yasuyuki ITABASHI, Ryo INOUE, Manabu OKADA, Yasushi OGASAWARA, Kuniaki TSUJINO, Akira HASEGAWA, Yasuhiro HATANO, Taketo YAMAGAMI, Hiroshi IWAMA, Toru SHIOKAWA, Yoshiaki TERAYAMA, Yasuo MINEMATSU, Kazuo |
author_facet | TOYODA, Kazunori KOGA, Masatoshi IGUCHI, Yasuyuki ITABASHI, Ryo INOUE, Manabu OKADA, Yasushi OGASAWARA, Kuniaki TSUJINO, Akira HASEGAWA, Yasuhiro HATANO, Taketo YAMAGAMI, Hiroshi IWAMA, Toru SHIOKAWA, Yoshiaki TERAYAMA, Yasuo MINEMATSU, Kazuo |
author_sort | TOYODA, Kazunori |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6923159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Japan Neurosurgical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-69231592019-12-23 Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society TOYODA, Kazunori KOGA, Masatoshi IGUCHI, Yasuyuki ITABASHI, Ryo INOUE, Manabu OKADA, Yasushi OGASAWARA, Kuniaki TSUJINO, Akira HASEGAWA, Yasuhiro HATANO, Taketo YAMAGAMI, Hiroshi IWAMA, Toru SHIOKAWA, Yoshiaki TERAYAMA, Yasuo MINEMATSU, Kazuo Neurol Med Chir (Tokyo) Special Topic The Japan Neurosurgical Society 2019-12 2019-12-05 /pmc/articles/PMC6923159/ /pubmed/31801934 http://dx.doi.org/10.2176/nmc.st.2019-0177 Text en © 2019 The Japan Neurosurgical Society This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Special Topic TOYODA, Kazunori KOGA, Masatoshi IGUCHI, Yasuyuki ITABASHI, Ryo INOUE, Manabu OKADA, Yasushi OGASAWARA, Kuniaki TSUJINO, Akira HASEGAWA, Yasuhiro HATANO, Taketo YAMAGAMI, Hiroshi IWAMA, Toru SHIOKAWA, Yoshiaki TERAYAMA, Yasuo MINEMATSU, Kazuo Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society |
title | Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society |
title_full | Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society |
title_fullStr | Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society |
title_full_unstemmed | Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society |
title_short | Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society |
title_sort | guidelines for intravenous thrombolysis (recombinant tissue-type plasminogen activator), the third edition, march 2019: a guideline from the japan stroke society |
topic | Special Topic |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923159/ https://www.ncbi.nlm.nih.gov/pubmed/31801934 http://dx.doi.org/10.2176/nmc.st.2019-0177 |
work_keys_str_mv | AT toyodakazunori guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT kogamasatoshi guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT iguchiyasuyuki guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT itabashiryo guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT inouemanabu guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT okadayasushi guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT ogasawarakuniaki guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT tsujinoakira guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT hasegawayasuhiro guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT hatanotaketo guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT yamagamihiroshi guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT iwamatoru guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT shiokawayoshiaki guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT terayamayasuo guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety AT minematsukazuo guidelinesforintravenousthrombolysisrecombinanttissuetypeplasminogenactivatorthethirdeditionmarch2019aguidelinefromthejapanstrokesociety |